Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Instagram X-twitter Linkedin-in Youtube
GET IN TOUCH

Aibo Medical Robot

Aibo Medical Robot is a medical robotics company that develops vascular interventional surgery robots
2020
Shenzhen, China

www.abrobo.com

HealthcareSurgical Robots
Innovation
Investment Funding
People
About
Products
Future Plan
Awards and Recognitions
M&A and Collabs
News

Innovation

Industry Problem

Complex vascular interventions expose clinicians to radiation and require precise remote catheter and guidewire manipulation.

R&D Focus

Robotic vascular intervention, catheter control and image-guided surgery.

Innovative Solution

A robotic platform remotely controls interventional tools to support coronary and other vascular procedures.

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

$32.9M

Last Funding Amount

$14 M

Last Funding Date

06-01-2023

Startup Stage

Growth Stage

Lead Investors

CDH, Alwin Capital, VGC (Innovation and Growth Fund), Yahui Investment, Changan Private Capital, Changling Capital

People

Founders

  • Shuxiang Guo
  • Guo Jian

CEO

  • Shuxiang Guo

About

Aibo Medical Robot is a medical robotics company that develops vascular interventional surgery robots

Products

Product

PANVIS-A vascular interventional surgical robot and aiboAngio platform.

Star Product

PANVIS-A, because it is the company’s registered commercial vascular-intervention robot.

Demo Product or Complete Product?

PANVIS-A received China Class III medical-device registration in 2024 and entered commercial launch; additional systems remain in development.

Future Plan

Market Expansion

Initial commercialization in China with plans to expand indications and hospital deployment.

Investment Funding

Raised approximately $14 million in a Series A round reported in 2023.

Awards and Recognitions

Certifications

China NMPA Class III medical-device registration for PANVIS-A, 2024.

M&A and Collabs

Collab

University of Shanghai for Science and Technology: complex coronary-lesion animal study using aiboAngio.

Collab

Hospitals in China: clinical validation and deployment of vascular-intervention robotics.

Something missing or incorrect on this page? Help us enrich this information

Claim Now and Contribute